Further reading

You may find the following resources helpful for further reading on the topic of MDS.

+ Public-friendly resources

• MDS UK: www.mdspatientsupport.org.uk
• MDS Foundation: www.mds-foundation.org/about-the-mds-foundation/
• AAMDS: www.aamds.org/
• MDS Alliance: www.mds-alliance.org/
• Leukaemia Care: www.leukaemiacare.org.uk/support-and-information/information-about-blood-cancer/blood-cancer-information/myelodysplastic-syndromes/
• Blood Cancer UK: www.bloodcancer.org.uk/understanding-blood-cancer/myelodysplastic-syndromes-mds/
• Cancer Research UK: www.cancerresearchuk.org/about-cancer/other-conditions/myelodysplastic-syndromes/about
• WebMD: www.webmd.com/cancer/lymphoma/myelodysplastic-syndrome-causes-symptoms-treatment#1
• National Health Service (NHS), UK: www.nhs.uk/conditions/myelodysplasia/

+ Clinical resources

• All clinical trials: www.ClinicalTrials.gov
• Arber D, Orazi A, Hasserjian R, et al, The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 2016: www.ashpublications.org/blood/article/128/3/462/35558/Arber-DA-Orazi-A-Hasserjian-R-et-al-The-2016
• British Society for Haematology, Guidelines for the Diagnosis and Management of Adult Myelodysplastic Syndromes, 2013: www.b-s-h.org.uk/guidelines/guidelines/diagnosis-and-management-of-adult-myelodysplastic-syndromes/
• Cogle C, Incidence and Burden of the Myelodysplastic Syndromes. Current Hematologic Malignancy Reports. 2015: www.pubmed.ncbi.nlm.nih.gov/26134527/
• Ma X. Epidemiology of myelodysplastic syndromes. American Journal of Medicine, 2012: www.pubmed.ncbi.nlm.nih.gov/22735748/
• Porwit A, Saft L,The AML–MDS interface—leukemic transformation in myelodysplastic syndromes. Journal of Hematopathology, 2011: www.link.springer.com/article/10.1007/s12308-011-0088-6

< Practical tips for managing low risk MDS